Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Benzphetamine Hydrochloride Tablets, USP CIII Rx Only
Medication labelWhy this: Advisory · dailymed-prescription
Benzphetamine hydrochloride tablets, USP are indicated in the management of exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient's weight, in kilograms (kg), divided by the patient's height, in meters (m), squared. Metric conversions are as follows: pounds ÷2.2 = kg; inches × 0.0254 = meters. The limited usefulness of agents of this class (See CLINICAL PHARMACOLOGY) should be weighed against possible risks inherent in their use such as those described below. Benzphetamine hydrochloride tablets, USP are indicated for use as monotherapy only.
- generic_name
- benzphetamine hydrochloride
- product_names
- BENZPHETAMINE HYDROCHLORIDE
- ndc
- 17224-672, 10702-040, 17224-672-30, 17224-672-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en